CLINICAL_TRIALS
trial_result
· 2022-02-28
Clinical Trial Update: Safety and Efficacy of AMG 827 in Subjects With RA [Phase 2]
Summary
Phase 2 clinical trial of AMG 827 in rheumatoid arthritis was terminated; results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Amgen | Conditions: Rheumatoid Arthritis | Phase 2 | Status: TERMINATED | Results posted: 2022-02-28